AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
about
Alzheimer's disease: Targeting the Cholinergic SystemCholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseAlzheimer's disease and age-related memory decline (preclinical)Advances in recent patent and clinical trial drug development for Alzheimer's disease.Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation.Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease.GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.Population-based study suggests an increased risk of Alzheimer'sdisease in Sjögren's syndrome.Therapeutics of Neurotransmitters in Alzheimer's Disease.
P2860
Q28070135-D0D209C3-FDCD-4584-A9F9-2FD6825FCDE1Q28287090-F9F0A8CF-295D-42B7-A76F-F983A6FFC8DFQ35041190-5F2E05CF-DACB-415E-8D38-DD8705CF1C00Q35738142-78C1AB94-DFF6-449E-9B73-C965B69EB825Q36219281-82464672-9A3A-4027-8E23-0632515D7443Q37318152-2514F119-FB74-4092-99C9-21DDB8582E40Q37961834-C0CF4E9E-C735-4ACB-BD5E-2367764519B7Q38225536-D1F13192-D5CA-4A17-80A3-C3C77C5B9DE6Q39774300-B029125D-F138-4718-9781-7F0705A916EEQ44842565-AC2EA412-45DA-4A17-B921-FA28EC59E0CCQ47306169-AECCB775-F098-43CC-A79E-8012A1CE2C96Q49672905-0C88ED6F-FDFC-4E5D-AE46-66EF7488D320
P2860
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@ast
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@en
type
label
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@ast
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@en
prefLabel
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@ast
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@en
P2093
P1476
AF150(S) and AF267B: M1 muscar ...... apies for Alzheimer's disease.
@en
P2093
Abraham Fisher
Hagar Sonego
Itzhak Marcovitch
Michal Kliger-Spatz
Niva Natan
Rachel Brandeis
Rachel Haring Nira Bar-Ner
Zipora Pittel
P2888
P304
P356
10.1007/S12031-002-0025-3
P577
2002-08-01T00:00:00Z
P6179
1047322301